Related content

Correlation between the overexpression of urokinase receptor isoform uPAR (D1D2) and hepatic cell malignant transformation

By Zhou Yingqun   L Xiaoping   Li Shan   Zhan Lingling  

Molecular Medicine Reports, Vol. 9, Iss. 5, 2014-05 ,pp. : 1689-1696

Spandidos Publications

Access to resources Recommend Favorite

Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients

By Chung Hyun   Rha Sun   Park Joon   Yoo Nae   Kim Joo   Roh Jae   Min Jin   Lee Kyong   Kim Byung   Kim Jin  

Breast Cancer Research and Treatment, Vol. 49, Iss. 1, 1998-05 ,pp. : 41-50

Springer Publishing Company

Access to resources Recommend Favorite

Hypoxia inducible factor-1 mediates upregulation of urokinase-type plasminogen activator receptor gene transcription during hypoxia in cervical cancer cells

By              

Oncology Reports, Vol. 35, Iss. 2, 2016-01 ,pp. : 992-998

Spandidos Publications

Access to resources Recommend Favorite

Clinical Relevance of Urokinase-Type Plasminogen Activator, Its Receptor, and Its Inhibitor Type 1 in Endometrial Cancer

By Tecimer C.   Doering D.L.   Goldsmith L.J.   Meyer J.S.   Abdulhay G.   Wittliff J.L.  

Gynecologic Oncology, Vol. 80, Iss. 1, 2001-01 ,pp. : 48-55

Elsevier

Access to resources Recommend Favorite

A d-amino acid containing peptide as a potent, noncovalent inhibitor of α5β1 integrin in human prostate cancer invasion and lung colonization

By Veine Donna   Yao Hongren   Stafford Daniel   Fay Kevin   Livant Donna  

Clinical and Experimental Metastasis, Vol. 31, Iss. 4, 2014-04 ,pp. : 379-393

Springer Publishing Company

Access to resources Recommend Favorite